Transaction Data Systems, parent company of Rx30 and Computer-Rx pharmacy software, announced yesterday that it has named Monty Rogers as its new chief strategy officer and chief pharmacist.
Rogers, a seasoned pharmacy professional, leads the company's corporate strategy. The company says that he was selected to join its leadership team because his unique viewpoint allows him to maintain the company's focus on developing market-leading solutions and strategies for the independent and community pharmacy. He brings more than 25 years of industry experience and his personal experience as a pharmacist, to the business. He most recently served as the founder and president of Pharm Assess Inc.
Rogers, said, 'I am excited to take on this role and have already witnessed the commitment by TDS to drive change and provide industry-leading solutions to ensure the pharmacist remains relevant in this continuously evolving healthcare market. I remain a pharmacist with an entrepreneurial spirit and am focused on leading the strategy of our company to ensure independent community pharmacies can impact and drive healthy outcomes for their communities and businesses.'
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project